• Direct Medica is specialised in remote management of sales and customer relations in the field of healthcare. The company has developed solutions for interaction between players in the healthcare sector, such as remote direct sales of medicine to pharmacies, remote training of healthcare professionals, patient monitoring programmes and pharmacovigilance. It assists the major pharmaceutical laboratories, like Pfizer and Astra, in monitoring their portfolios of client pharmacies and in improving the traceability of their specialities. Directmedica provides support for the distribution of medicine.

Direct Medica, in 2010, employed 350 people (telemarketers, counsellors, medical visitors, doctors, pharmacists, nurses, dieticians, etc.) split between the two sites at Boulogne-Billancourt and Lyon.

• Management : Jean-Christian Kipp, Jérôme Stevens and Sophie Kerob-Schönborn
• http://www.directmedica.com/
• Nature of the deal: OBO
• Date of the first investment: March 2011


• Led by an experienced management team, Direct Medica is a rapidly growing company involved in a number of attractive market segments within a highly-resilient sector. Positioned today at the heart of the health delivery ecosystem, the company provides solutions for interaction between laboratories, health professionals and, to an increasing extent, patients themselves, a role that promises the creation of new growth outlets over the coming years. The transaction will enable the company to launch new services and to accelerate its international development.



PRESS RELEASE:
> Capzanine acquires a minority stake in Direct Medica (Capzanine 05/2011)